Format

Send to

Choose Destination
Curr Top Microbiol Immunol. 2015;391:237-61. doi: 10.1007/978-3-319-22834-1_8.

Epstein-Barr Virus Lytic Cycle Reactivation.

Author information

1
Department of Pediatrics, Division of Infectious Diseases, Yale University School of Medicine, New Haven, CT, 06520, USA.
2
Department of Pediatrics, Division of Infectious Diseases, Yale University School of Medicine, New Haven, CT, 06520, USA. ayman.el-guindy@yale.edu.

Abstract

Epstein-Barr virus, which mainly infects B cells and epithelial cells, has two modes of infection: latent and lytic. Epstein-Barr virus infection is predominantly latent; however, lytic infection is detected in healthy seropositive individuals and becomes more prominent in certain pathological conditions. Lytic infection is divided into several stages: early gene expression, DNA replication, late gene expression, assembly, and egress. This chapter summarizes the most recent progress made toward understanding the molecular mechanisms that regulate the different lytic stages leading to production of viral progeny. In addition, the chapter highlights the potential role of lytic infection in disease development and current attempts to purposely induce lytic infection as a therapeutic approach.

KEYWORDS:

BZLF1; DNA methylation; EBV DNA replication; EBV-associated diseases; Lytic infection; Oncolytic

PMID:
26428377
DOI:
10.1007/978-3-319-22834-1_8
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Springer
Loading ...
Support Center